Rigas JR - Search Results

1

Phase I clinical and pharmacological study of chloroquinoxaline sulfonamide.

Rigas JR, Tong WP, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Cancer Res. 1992 Dec 1;52(23):6619-23. Cancer Res. 1992. PMID: 1423306 Clinical Trial.

2

Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.

Francis PA, Kris MG, Rigas JR, Grant SC, Miller VA. Francis PA, et al. Among authors: rigas jr. Lung Cancer. 1995 Apr;12 Suppl 1:S163-72. doi: 10.1016/0169-5002(95)00432-z. Lung Cancer. 1995. PMID: 7551925 Free article. Review.

3

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.

Miller VA, Rigas JR, Francis PA, Grant SC, Pisters KM, Venkatraman ES, Woolley K, Heelan RT, Kris MG. Miller VA, et al. Among authors: rigas jr. Cancer. 1995 Feb 15;75(4):968-72. doi: 10.1002/1097-0142(19950215)75:4<968::aid-cncr2820750411>3.0.co;2-y. Cancer. 1995. PMID: 7842417 Clinical Trial.

4

Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule.

Rigas JR, Francis PA, Miller VA, Tong WP, Roistacher N, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Cancer Chemother Pharmacol. 1995;35(6):483-8. doi: 10.1007/BF00686832. Cancer Chemother Pharmacol. 1995. PMID: 7882456 Clinical Trial.

5

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.

Francis PA, Rigas JR, Kris MG, Pisters KM, Orazem JP, Woolley KJ, Heelan RT. Francis PA, et al. Among authors: rigas jr. J Clin Oncol. 1994 Jun;12(6):1232-7. doi: 10.1200/JCO.1994.12.6.1232. J Clin Oncol. 1994. PMID: 7911159 Clinical Trial.

6

Modulation of all-trans retinoic acid pharmacokinetics by liarozole.

Miller VA, Rigas JR, Muindi JR, Tong WP, Venkatraman E, Kris MG, Warrell RP Jr. Miller VA, et al. Among authors: rigas jr. Cancer Chemother Pharmacol. 1994;34(6):522-6. doi: 10.1007/BF00685665. Cancer Chemother Pharmacol. 1994. PMID: 7923564 Clinical Trial.

7

Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans-retinoic acid in patients with advanced cancer.

Muindi JF, Scher HI, Rigas JR, Warrell RP Jr, Young CW. Muindi JF, et al. Among authors: rigas jr. Cancer Res. 1994 Apr 15;54(8):2125-8. Cancer Res. 1994. PMID: 8174117

8

Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.

Rigas JR, Francis PA, Muindi JR, Kris MG, Huselton C, DeGrazia F, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. J Natl Cancer Inst. 1993 Dec 1;85(23):1921-6. doi: 10.1093/jnci/85.23.1921. J Natl Cancer Inst. 1993. PMID: 8230282 Clinical Trial.

9

The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.

Baltzer L, Kris MG, Tyson LB, Rigas JR, Pisters KM. Baltzer L, et al. Among authors: rigas jr. Cancer. 1994 Feb 1;73(3):720-3. doi: 10.1002/1097-0142(19940201)73:3<720::aid-cncr2820730336>3.0.co;2-3. Cancer. 1994. PMID: 8299095 Clinical Trial.

10

Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapy.

Baltzer L, Kris MG, Tyson LB, Rigas JR, Vreeland F, Pisters KM. Baltzer L, et al. Among authors: rigas jr. Cancer. 1993 Nov 1;72(9):2695-9. doi: 10.1002/1097-0142(19931101)72:9<2695::aid-cncr2820720928>3.0.co;2-s. Cancer. 1993. PMID: 8402492 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters